ADD/ADHD News

Low-dose ketamine was generally safe, well-tolerated and effective in treating clinical symptoms in a small group of children with activity-dependent neuroprotective protein syndrome, researchers reported.

Children of women with gestational diabetes and pregestational obesity are more likely to develop ADHD than offspring of women with normal weight, according to study findings.

Children born before 39 weeks are more likely to experience symptoms related to ADHD, according to data published in The Journal of Pediatrics.

McLean Hospital in Belmont, Massachusetts, has been named the top hospital in the United States for psychiatric care by the U.S. News & World Report for 2022 to 2023.

Allergic disorders in early childhood significantly increase the risks for ADHD and, to a lesser extent, autism spectrum disorder, according to a study published in Pediatric Allergy and Immunology.

Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ADHD symptoms or diagnosis at 5 years of age, according to a Norwegian registry-based study.

Pediatric behavioral health company Elemy has announced centralized diagnosis-to-treatment services to provide faster clinical support and comprehensive care for children suffering from behavioral, emotional and developmental disorders.

NEW ORLEANS – The American Psychiatric Association DSM steering committee gathered at the APA annual meeting to review proposed changes to the manual, committee chair Paul S. Appelbaum, MD, said.

NEW ORLEANS – For the first time in 3 years, the American Psychiatric Association will host its annual meeting in person, May 21 to 25 in New Orleans, with social determinants of mental health as the conference theme.

Supernus Pharmaceuticals announced FDA approval of viloxazine extended-release capsules to treat ADHD in patients aged 18 years and older.